​

Surrozen (SRZN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

SRZN Stock Forecast

Surrozen (SRZN) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $42.00, with a high of $44.00 and a low of $40.00. This represents a 79.72% increase from the last price of $23.37.

$5 $13 $21 $29 $37 $45 High: $44 Avg: $42 Low: $40 Last Closed Price: $23.37

SRZN Stock Rating

Surrozen stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (66.67%), 0 Hold (0.00%), 2 Sell (33.33%), and 0 Strong Sell (0.00%).

Buy
Total 6 2 0 4 0 Strong Sell Sell Hold Buy Strong Buy

SRZN Price Target Upside V Benchmarks

TypeNameUpside
StockSurrozen79.72%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-12
Avg Price Target-$44.00$42.00
Last Closing Price$23.37$23.37$23.37
Upside/Downside-88.28%79.72%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 26-5---5
May, 26-5---5
Apr, 26-4---4
Mar, 26-4---4
Feb, 26-3---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 07, 2026H.C. Wainwright$44.00$34.1328.92%88.28%
Feb 19, 2026Cantor Fitzgerald$40.00$25.0959.43%71.16%
Jan 30, 2025Matthew CaufieldH.C. Wainwright$32.00$11.25184.44%36.93%
Jan 03, 2025Yatin SunejaGuggenheim$45.00$17.45157.88%92.55%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 07, 2026H.C. WainwrightBuyBuyhold
Apr 21, 2026Cowen & Co.Buyinitialise
Mar 24, 2026H.C. WainwrightBuyBuyhold
Feb 19, 2026Cantor FitzgeraldOverweightinitialise
Jan 30, 2025H.C. WainwrightBuyinitialise
Jan 03, 2025GuggenheimBuyupgrade
Nov 17, 2022Credit SuisseUnderperformdowngrade

Financial Forecast

EPS Forecast

$-35 $-28 $-21 $-14 $-7 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-21.33$-21.67$-32.37---
Avg Forecast$-18.23$-13.61$-4.15$-2.71$-1.00$-1.01
High Forecast$-18.23$-13.61$-4.15$-2.71$-1.00$-1.01
Low Forecast$-18.23$-13.61$-4.15$-2.71$-1.00$-1.01
Surprise %17.00%59.22%680.00%---

Revenue Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$10.65M$3.48M---
Avg Forecast$12.50M$10.00M----
High Forecast$12.50M$10.00M----
Low Forecast$12.50M$10.00M----
Surprise %-6.55%----

Net Income Forecast

$-65M $-52M $-39M $-26M $-13M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-43.04M$-63.56M----
Avg Forecast$-36.78M$-27.46M$-8.37M$-5.47M$-2.02M$-2.04M
High Forecast$-36.78M$-27.46M$-8.37M$-5.47M$-2.02M$-2.04M
Low Forecast$-36.78M$-27.46M$-8.37M$-5.47M$-2.02M$-2.04M
Surprise %17.03%131.44%----

SRZN Forecast FAQ

Is Surrozen stock a buy?

Surrozen stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Surrozen is a favorable investment for most analysts.

What is Surrozen's price target?

Surrozen's price target, set by 6 Wall Street analysts, averages $42 over the next 12 months. The price target range spans from $40 at the low end to $44 at the high end, suggesting a potential 79.72% change from the previous closing price of $23.37.

How does Surrozen stock forecast compare to its benchmarks?

Surrozen's stock forecast shows a 79.72% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Surrozen over the past three months?

  • June 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Surrozen’s EPS forecast?

Surrozen's average annual EPS forecast for its fiscal year ending in December 2026 is $-2.71, marking a -91.63% decrease from the reported $-32.37 in 2025. Estimates for the following years are $-1 in 2027, and $-1.01 in 2028.

What is Surrozen’s revenue forecast?

Surrozen's average annual revenue forecast for its fiscal year ending in December 2026 is $0, reflecting a -100.00% decrease from the reported $3.48M in 2025. The forecast for 2027 is $0, and $0 for 2028.

What is Surrozen’s net income forecast?

Surrozen's net income forecast for the fiscal year ending in December 2026 stands at $-5.469M, representing a 0% decrease from the reported $0 in 2025. Projections indicate $-2.018M in 2027, and $-2.038M in 2028.